Life Science Company News

Results 241 - 260 out of 500 displayed.

By: PR Newswire Association LLC. - 24 Apr 2024

Kanazawa University research: Biochemical tails tell a story

By: PR Newswire Association LLC. - 24 Apr 2024

SciBase Partners with Al Shirawi Healthcare solutions to Offer Nevisense in UAE

By: PR Newswire Association LLC. - 24 Apr 2024

Related companies: SciBase Holding AB

Calliditas Announces Positive NefIgArd Open Label Extension Results

By: PR Newswire Association LLC. - 24 Apr 2024

Related companies: Calliditas Therapeutics AB

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

By: PR Newswire Association LLC. - 24 Apr 2024

Geek+ and System Teknik deploy first PopPick solution in the Nordics for the pharmacy group Med24.dk

By: PR Newswire Association LLC. - 24 Apr 2024

Tetra Pharm Technologies and Glysious Announce Collaboration to Develop Transdermal Combination Drugs Targeting the Endocannabinoid System

By: PR Newswire Association LLC. - 24 Apr 2024

TVM Capital Healthcare Announces US$ 17 Million Investment into neurocare

By: PR Newswire Association LLC. - 24 Apr 2024

Esaote Group: Shareholders' Meeting approves financial statements as of 31 December 2023

By: PR Newswire Association LLC. - 24 Apr 2024

CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy

By: PR Newswire Association LLC. - 24 Apr 2024

Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares

By: GlobeNewswire - 24 Apr 2024

Related companies: Centessa Pharmaceuticals Limited

Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria

By: GlobeNewswire - 24 Apr 2024

Related companies: Novartis AG | Novan, Inc.

[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19

By: GlobeNewswire - 24 Apr 2024

Related companies: F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche Ltd | Hoffmann-La Roche Ltd. (Edmonton)

Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates

By: GlobeNewswire - 24 Apr 2024

Related companies: Vivoryon Therapeutics N.V.

BioSenic postpones its annual general meeting of the shareholders and provides temporary non-audited financial figures for 2023

By: GlobeNewswire - 24 Apr 2024

Related companies: BioSenic SA

Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance

By: GlobeNewswire - 24 Apr 2024

Related companies: Ipsen SA

Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards

By: GlobeNewswire - 24 Apr 2024

Related companies: Pharming Group N.V.

RELIFE BY A. MENARINI CHAMPIONS PERSONAL CHOICE IN AESTHETIC TREATMENTS, ENCOURAGING SELF-CARE AND SELF-LOVE

By: PR Newswire Association LLC. - 24 Apr 2024

GenScript Singapore's Open Day Reveals Pioneering AI Capabilities in Recombinant Protein Production and Drug Discovery

By: PR Newswire Association LLC. - 24 Apr 2024

Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab)

By: PR Newswire Association LLC. - 24 Apr 2024

Results 241 - 260 out of 500 displayed.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

Enhance your business development with Biotechgate

Try for free »